Caris Life Sciences to Report Fourth Quarter and Full Year 2025 Financial Results on February 26
Prnewswire· 2026-02-09 13:30
Core Insights - Caris Life Sciences will report its fourth quarter and full year 2025 financial results on February 26, 2026, and will host a conference call to discuss these results [1] Company Overview - Caris Life Sciences is a leading, patient-centric, next-generation AI TechBio company and precision medicine pioneer, focused on developing and commercializing innovative healthcare solutions [2] - The company utilizes comprehensive molecular profiling, including Whole Genome, Whole Exome, and Whole Transcriptome Sequencing, combined with advanced AI and machine learning to analyze the molecular complexity of diseases [2] - Caris has established a large-scale, multimodal clinico-genomic database and computing capability, which supports the development of advanced precision medicine diagnostic solutions for early detection, diagnosis, monitoring, therapy selection, and drug development [2] Company Background - Founded with the vision to harness the potential of precision medicine to enhance human health, Caris Life Sciences is headquartered in Irving, Texas, with additional offices in Phoenix, New York, Cambridge (MA), Tokyo, Japan, and Basel, Switzerland [3] - The company or its distributor partners provide services in the U.S. and various international markets [3]
Expand Energy Announces Headquarters Relocation to Houston and Appointment of Michael Wichterich as Interim CEO
Globenewswire· 2026-02-09 13:30
Headquarters relocation accelerates Company's strategy to connect its leading scale to growing marketsCompany reaffirms synergy, capital and operating outlook for the fourth quarter and full year 2025 OKLAHOMA CITY, Feb. 09, 2026 (GLOBE NEWSWIRE) -- Expand Energy Corporation (NASDAQ: EXE) (“Expand Energy” or the “Company”) today announced plans to relocate its corporate headquarters from Oklahoma City, Oklahoma, to Houston, Texas, in mid-2026. The relocation, which will primarily focus on the executive lead ...
Labcorp Appoints John H. Sampson, M.D.
Prnewswire· 2026-02-09 13:30
BURLINGTON, N.C., Feb. 9, 2026 /PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, today announced the appointment of John H. Sampson, M.D., Ph.D., MHSc, MBA, to its Board of Directors, effective February 9, 2026. Continue Reading Dr. John H. Sampson Dr. Sampson serves as vice chancellor for health affairs and dean of the University of Colorado Anschutz School of Medicine at the CU Anschutz medical campus. As a nationally recognized neu ...
Baird Medical Accelerates Global Commercial Roadmap with Strategic Clinical Education Initiatives in the U.S. and Japan
Prnewswire· 2026-02-09 13:30
In New York, the Company successfully facilitated an advanced training initiative at the Columbia University Irving Medical Center, led by Dr. Jennifer Kuo, Director of the Interventional Endocrinology Program and Fellowship Director at Columbia University. This high-level collaboration empowered distinguished specialists Dr. Todd Frieze and Dr. Alberto Monreal from Duke Health, to refine techniques in minimally invasive therapies, including Baird Medical´s Microwave Ablation System for the treatment of Ben ...
Guardforce AI Signs Non-binding Letter of Intent to Acquire Leading AI-Powered Speech Therapy and Development Platform
Globenewswire· 2026-02-09 13:30
NEW YORK, NY, Feb. 09, 2026 (GLOBE NEWSWIRE) -- Guardforce AI Co., Limited (“Guardforce AI” or the “Company”) (NASDAQ: GFAI, GFAIW), an AI-driven technology company providing Agentic AI, smart solutions in automation, robotics, and secured logistics, today announced it has entered into a non-binding Letter of Intent (LOI) to acquire 100% of the issued and outstanding share capital of MGAI Limited (“MGAI”), a pioneer in AI-driven solutions for speech therapy and development management and rehabilitation serv ...
Foremost Clean Energy Announces 5,000-Metre Follow-Up Drill Program at Hatchet Lake Uranium Project
Globenewswire· 2026-02-09 13:30
Core Viewpoint - Foremost Clean Energy Ltd. is set to initiate a 5,000-metre diamond drill program at its Hatchet Lake Uranium Project in mid-February 2026, following a successful 2025 winter drill program that led to a new uranium discovery [1][2]. Drill Program Overview - The upcoming drill program aims to systematically follow up on the TF-25-16 discovery, which intersected 0.87% U₃O₈ over 0.45 metres within a broader 6.2-metre interval averaging 0.10% U₃O₈ [1][5]. - The program will focus on multiple high-priority targets, including Tuning Fork and Beta Grid at Hatchet Lake South, and Richardson SE at Hatchet Lake North [3][12]. Target Areas - The Tuning Fork target area will be prioritized for step-out and infill drilling to test the continuity of mineralization and refine structural controls [5][7]. - Tuning Fork West has identified a previously untested electromagnetic conductor approximately 1.2 kilometres in strike length, which is considered a high-priority target [9]. - The Beta Grid target area shows a 20.3-metre offset in the depth to the Athabasca unconformity, interpreted as an east-directed thrust fault, which will be evaluated through targeted drilling [10]. - The Richardson SE target area contains over 5 kilometres of untested electromagnetic conductor strike length, with recent ground gravity survey results being integrated to refine drill targets [12]. Exploration Outlook - The drill program is designed to advance additional drill-ready targets generated through integrated geological and geophysical interpretation, with a focus on identifying zones of structural complexity and hydrothermal alteration [15][20]. - The company believes that the combination of newly identified untested conductors and confirmed structural complexity makes Hatchet Lake a compelling project for further uranium discoveries [15].
XTI Aerospace Reports Accelerating Revenue Growth and Expected 2026 Cash Flow at Shareholder Town Hall
Prnewswire· 2026-02-09 13:30
2026 revenue expected to exceed $160 million, representing approximately 30% growth ENGLEWOOD, Colo., Feb. 9, 2026 /PRNewswire/ -- XTI Aerospace, Inc. (Nasdaq: XTIA) ("XTI Aerospace," "XTI," or the "Company") an aerospace technology company focused on building and scaling its Drone Nerds, LLC ("Drone Nerds") subsidiary, a drone platform serving enterprise and government customers, on Thurs., Feb. 5, 2026, described its operating leverage, expanding customer base and commitment to near-term value creation d ...
Supremex Announces Date of Its 2025 Fourth Quarter Results Conference Call
Globenewswire· 2026-02-09 13:30
Core Viewpoint - Supremex Inc. is set to release its fourth-quarter results for the period ending December 31, 2025, on February 19, 2026, before market opening, followed by a conference call to discuss these results [1]. Group 1: Company Overview - Supremex is a leading North American manufacturer and marketer of envelopes and is expanding its offerings in paper-based packaging solutions [3]. - The company operates nine manufacturing facilities across four provinces in Canada and four facilities in three states in the United States, employing approximately 900 people [3]. - Supremex has a robust network that enables efficient manufacturing and distribution of envelope and packaging solutions tailored to the needs of major corporations, direct mailers, resellers, government entities, SMEs, and solutions providers [3]. Group 2: Conference Call Details - A live broadcast of the conference call will be available on the company's website under the Investors section [2]. - Participants from the professional investment community are encouraged to call in at least five minutes before the scheduled start time [2]. - A replay of the conference call will be accessible on the company's website and via a toll-free number until February 26, 2026 [2].
IGC Pharma Expands Phase 2 CALMA Trial into Colombia's Premier Alzheimer's Research Center
Accessnewswire· 2026-02-09 13:30
- Adds world renowned GNA site to broaden genetic diversity and strengthen path toward 2026 data catalyst - POTOMAC, MARYLAND / ACCESS Newswire / February 9, 2026 / IGC Pharma, Inc. (NYSE American:IGC) ("IGC" or the "Company") today announced the expansion of its Phase 2 CALMA trial for IGC-AD1 into Colombia, South America, through the addition of Grupo de Neurociencias de Antioquia ("GNA"). This expansion marks a pivotal operational milestone as IGC enters a region internationally recognized for its unique ...
Verisk Names Steven Kauderer President of Claims Solutions
Globenewswire· 2026-02-09 13:30
Core Insights - Verisk has appointed Steven Kauderer as the president of its Claims Solutions business, effective immediately [1][9] - Kauderer brings over 30 years of experience in the insurance industry, having previously held senior roles at EY-Parthenon, McKinsey & Company, Bain & Company, and Oliver Wyman [2][3] - The appointment aims to enhance the claims process for insurers and policyholders through improved accuracy, efficiency, and speed [2][5] Leadership and Experience - Steven Kauderer previously led the transformation practice at EY-Parthenon, focusing on increasing value and driving profitable growth for financial services organizations [3] - His background includes leadership in global insurance practices with a focus on property and casualty and life insurance [3] - Kauderer holds a bachelor's degree from Vassar College and an MBA from Yale University [4] Company Overview - Verisk is a strategic data analytics and technology partner for the global insurance industry, helping clients improve operational efficiency and make informed decisions about global risks [6] - The company operates in over 20 countries and is recognized for fostering an inclusive culture [6]